Non-cardiac Surgery in Valvular Heart Disease

Similar documents
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE

Valvular Heart Disease

Valve Disease in the Pregnant Patient

RF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford

Cardiac disease in pre pr gnancy

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012

Valvular Heart Disease Mitral Stenosis

Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital

HFpEF. April 26, 2018

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors:

When to implant an ICD in systemic right ventricle?

Hemodynamic Monitoring

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital

Images in Cardiovascular Medicine

Adult Echocardiography Examination Content Outline

Peripartum management of Rheumatic Heart Disease

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Drs. Rottman, Salloum, Campbell, Muldowney, Hong, Bagai, Kronenberg

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man.

Mitral Valve Disease, When to Intervene

Congestive Heart Failure or Heart Failure

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Management of Aortic Valve Disease: Review Questions

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

Heart Valves: Before and after surgery

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

Title of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis

A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC

Pregnancy and Heart Disease. Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA

EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE. Karen Stout, MD University of Washington Seattle Children s Seattle, WA

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

VALVULAR HEART DISEASE

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

On Referral to our Unit

Rheumatic heart disease in pregnancy

The Causes of Heart Failure

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Review of Cardiac Mechanics & Pharmacology 10/23/2016. Brent Dunworth, CRNA, MSN, MBA 1. Learning Objectives

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Effect of Heart Rate on Tissue Doppler Measures of E/E

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Valvular defects. Lectures from Pathological Physiology. Study materials from Pathological Physiology, 2017/2018 Oliver Rácz, Eva Sedláková

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Pulmonary Hypertension: Another Use for Viagra

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Survival Rates of Children with Congenital Heart Disease continue to improve.

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna

The Effect of Valvular Heart Diseases on Maternal and Fetal Outcome of Pregnancy Nada Salih Ameen*,Nawfal Fawzi Anwer**

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

Congenital heart disease. By Dr Saima Ali Professor of pediatrics

Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη

Index. Note: Page numbers of article titles are in boldface type.

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Indication, Timing, Assessment and Update on TAVI

MITRAL STENOSIS. Joanne Cusack

Spotlight on Valvular Heart Disease Guidelines

Common Codes for ICD-10

Title:Relation Between E/e' ratio and NT-proBNP Levels in Elderly Patients with Symptomatic Severe Aortic Stenosis

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Case # 1. Page: 8. DUKE: Adams

Repair or Replacement

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Dr. J. R. Rawal 1 ; Dr. H. S. Joshi 2 ; Dr. B. H. Roy 3 ; Dr. R. V. Ainchwar 3 ; Dr. S. S. Sahoo 3 ; Dr. A. P. Rawal 4 ; Dr. R. A.

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Cardiac Pathology & Rehabilitation

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Hypertension in Aortic Valve Disease

Comprehensive Cardiology: Matters of the Heart Class III SARAH BEANLANDS RN BSCN MSC

Cardiology Competency Based Goals and Objectives

SESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM

Outline. Maternal Congenital Heart Disease in Pregnancy. Maternal congenital heart disease. Cardiovascular disease in pregnancy 10/18/2017

Organic mitral regurgitation

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

ARRHYTHMIAS AND DEVICE THERAPY

Ventricular tachyarrhythmia during pregnancy in women with heart disease: data from the ROPAC

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Congenital Heart Disease Patient and Pregnancy

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

UC SF DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE OBJECTIVES. No financial disclosures CARDIOVASCULAR CHANGES ANTEPARTUM 6/10/2011

Cardiology. the Sounds: #7 HCM. LV Outflow Obstruction: Aortic Stenosis. (Coming Soon - HCM)

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

A study of atrial fibrillation with reference to clinical presentations and aetiologies

Transcription:

Jafar Golshahi, MD; Shahnaz Aram, MD Abstract Background- Valvular heart disease is one of the common complications of acute rheumatic fever, which manifests its clinical complications one or two decades after the primary attack of the disease in adults. The disease may involve one or more valves as stenosis or regurgitation or both and may cause congestive heart failure due to chronic volume or pressure overload. Method- This prospective study was performed from March 1999 to February 2001 in university affiliated medical centers. 53 patients (28 females and 25 males) who suffered from valvular heart disease in the form of mitral and aortic stenosis or regurgitation were studied. Most of the patients were in functional class I or II (44) and the rest (9) in class III and IV. Non-cardiac surgery procedures were laparotomy, orthopedic surgery, and thoracotomy. Results- Class I patients were able to easily tolerate the surgery without any significant problems. Only 2 patients had atrial in this class. In class II, one case had paroxysmal supraventricular tachycardia after thoracotomy and 3 patients had atrial. Another patient in this class had acute pulmonary edema. In class III, one patient had atrial fibrillation with rapid ventricular response after vaginal delivery. Of the two class IV patients, one patient needed reoperation due to prosthetic valve malfunction in the 26th week of pregnancy and the other had no significant hemodynamic problem. Discussion- Supraventricular arrhythmia, which occurs as atrial fibrillation or V paroxysmal supraventricular tachycardia or sinus tachycardia mostly in the first 24 hours after surgery, is preventable with sufficient analgesic prescription. Careful monitoring is necessary in patients with severe mitral or aortic stenosis and double valve disease during surgery or the first 24 hours after surgery. As a result, the important factor in patient prognosis is the functional class of heart disease rather than the type of valvular disease. (Iranian Heart Journal. 2002; 2(4)&3(1): 44-47) Key words: rheumatic heart disease<valvular disease<atrial fibrillation alvular heart disease, the clinical manifestations of which occur mostly in adults, is mainly a complication of acute rheumatic fever in our country. Cardiac involvement after acute rheumatic fever usually presents as stenosis or regurgitation of one, two or rarely three valves. 1 Complications of congenital valvular heart disease such as aortic or pulmonary stenosis are mostly discovered in childhood or even infancy on clinical examination. 2 Multi-valvular diseases such as mitral or aortic stenosis and regurgitation are characteristically sequelae of rheumatic heart disease. 3 Some valvular diseases such as mitral and tricuspid stenosis are very rare in congenital form; therefore, the presence of

such disorders even in isolated forms can From the Department of Cardiology, Khorshid Hospital, Isfahan, Iran Correspondence to J. Golshahi, MD, Khorshid Hospital, Isfahan, Iran Email: golshahi@meb.mui.ac.ir Fax: +(98311) 6691561 past. Valvular diseases such as aortic and mitral stenosis cause pressure overload on the heart. Such disorders have severe hemodynamic complications and lead to symptoms sooner. In contrast, diseases such as chronic mitral and aortic regurgitation, which cause cardiac volume overload, are tolerated for a long period even without specific treatment. 5 In mitral stenosis, left ventricular filling is obstructed, which causes an increase in left atrial pressure and consequently pulmonary venous pressure and pulmonary capillary wedge pressure (PCWP) are elevated, and in the long-term, it can cause pulmonary hypertension and right heart failure. 6 On the other hand, cardiac output decreases due to impeded ventricular filling. In mild or moderate aortic stenosis no significant problem occurs. But in severe stenosis with a valve orifice area of 1 cm 2 or less, angina, syncopal attacks or left ventricular systolic dysfunction occurs. Management of such patients is difficult during non-cardiac surgeries such as laparotomy, thoracotomy, delivery, cesarean section, etc. Because due to static stenosis as a result of fibrosis, calcification and cusp deformity, the patient has a fixed cardiac output owing to fixed left ventricular outflow tract obstruction and cannot increase it in stressful conditions, such as surgical operations. Therefore, excessive fluid therapy causes volume overload and acute pulmonary edema and high dose diuretic administration decreases cardiac output with its possible complications, such as acute tubular necrosis. In valvular lesions in the form of aortic or mitral regurgitation, there is no significant problem with preserved LV systolic function. So special effort is not necessary before surgery and such patients have no significant hemodynamic problem be indicative of rheumatic fever in the for general anesthesia and surgical operations. 8 In all valvular heart diseases, prophylaxis against infective endocarditis should be done before surgery. 8 Due to high prevalence of valvular heart diseases as a sequel of acute rheumatic fever, the necessity of this study is obvious. The goal of this study is to determine high-risk patients with valvular heart problems undergoing non-cardiac surgery. New York Heart Association (NYHA) classifies cardiac patients into four groups: class I and II patients tolerate surgical operations and general anesthesia easily without a significant problem. In class III underlying factors of heart failure exacerbation such as anemia, infection, arrhythmia, etc. should be corrected before surgical operations. Thus the degree of heart failure decreases one or two classes, and it is probable that the patient be prepared for surgery. In class IV it is recommended that cardiac disease be treated before noncardiac surgical operations due to the etiology of disease. Of course, in these cases exacerbating factors of heart failure should be corrected. Methods and Materials This prospective descriptive analytic study was done over a 2-year period from March 1999 to February 2001 in medical centers affiliated to Isfahan University of Medical Sciences. 53 patients (28 female and 25 male) with an age average of 35.5 ア 11.3 years male, 35.1 ア 11.7 years female, ranging from 17 to 59 years, were studied. 39 had mitral stenosis and regurgitation, 11 had mitral stenosis and aortic regurgitation, 5 mitral stenosis, aortic stenosis and regurgitation and 5 had pure mitral stenosis. 19 patients were in class I,

25 in class II, 7 in class III and 2 in class IV. The type and severity of valvular disease were assessed by one cardiologist with echo Doppler study. The surgical operations performed on the patients were as follows: 24 laparotomies, 17 cesarean sections, 7 vaginal deliveries, 2 orthopedic operations, 3 thoracotomies. Of the 24 laparotomies, 21 were elective and 3 were urgent (2 appendicitis, 1 ectopic pregnancy). Three thoracotomies were performed for bronchiectasis. Results Among 19 class I patients, 16 tolerated surgical operations easily, one case suffered from sinus tachycardia 12 hours after cholecystectomy with a heart rate of 130 bpm and recovered with analgesic administration, and two of the patients who showed atrial fibrillation with rapid ventricular response in the first 24 hours after surgery were controlled with digitalis administration. Among 25 class II patients, one had paroxysmal supraventricular tachycardia (PSVT) after thoracotomy. This patient had mitral stenosis plus aortic regurgitation and sinus rhythm. Three showed atrial fibrillation with rapid ventricular response, two of whom had controlled atrial fibrillation before surgery and the other, who had sinus rhythm, showed atrial fibrillation after surgery but ventricular response was controlled. One patient had acute pulmonary edema after extubation and recovered with prompt treatment. This patient had mitral stenosis and regurgitation and a valve orifice area of 1.45cm 2. Other class II patients (20 patients) had no significant hemodynamic or rhythm problem. Among 7 class III patients, six had double valve disease and one had severe mitral stenosis and moderate mitral regurgitation (valve area = 1.1cm 2 ). The latter showed atrial after vaginal delivery, which was controlled. Six other patients did not show significant hemodynamic changes during and after laparotomy and with preventive medical care such as heart failure treatment. From the 2 class IV patients, one underwent MVR and therefore had a metallic mitral valve and was under treatment with heparin during pregnancy. This patient showed acute pulmonary edema in the 26th week of gestation and was reoperated on with a diagnosis of prosthetic valve malfunction. The other case rose to class III with correction of anemia and heart failure treatment and had no complications during and after laparotomy. Discussion Among 19 class I patients, one had sinus tachycardia after surgery and two showed atrial fibrillation with rapid ventricular response, which is mainly thought to be due to the pain of the incision site and can be prevented with analgesic administration. In Diker s study, valvular patients show supraventricular arrhythmia in the form of atrial fibrillation or PSVT (paroxysmal supraventricular tachycardia) in the first 24 hours after surgery and prophylactic analgesic administration is recommended in such patients. 9 In class II patients, supraventricular arrhythmia also occurred, which is completely logical due to the severity of heart disease in this class compared to class I. In two patients, atrial was controlled after surgery, which is considered to need a higher dose of _- blockers or digitalis or verapamil. Of course, other exacerbating factors of arrhythmia such as anemia, fever, infection and pain should be considered. One patient with mitral stenosis and regurgitation developed acute pulmonary edema after extubation. It has been mentioned in Eagle s study that in cardiac patients, especially those with mitral stenosis, acute pulmonary edema may occur due to an increase in wedge pressure (PCWP) after

extubation in the recovery room. That is because the positive pressure caused by mechanical ventilation stops fluid leakage from pulmonary capillaries to interstitial space and later to alveoli. 10 Among 7 class III patients, only 1 who had severe mitral stenosis (valve area 1.1cm 2 ) showed atrial after vaginal delivery. This is a result of overload and fluid shift from the extracellular to intravascular space and is the beginning of imminent acute pulmonary edema. In the study of David and colleagues it has been mentioned that some valvular diseases, especially severe mitral and aortic stenosis, should be monitored carefully during surgery. 11 In aortic stenosis it is necessary for the patient to have a Swan-Ganz catheter to maintain the PCWP near 18mmHg so that cardiac output will be high enough to tolerate surgery and prevent pulmonary edema in case of an increase in wedge pressure. 12 Patients with severe mitral or aortic stenosis should first undergo valve repair or replacement, then be prepared for surgical operations or pregnancy. Lack of mortality in this study is probably due to low functional class of patients (class I and II in 83%, class III and IV only 17%). In Norman s study, mortality of surgical operations in severe mitral stenosis was 7%. 13 In this study, all patients with aortic stenosis had mild to moderate disease. Therefore, aside from severity of valvular disease, which is a determining factor in surgical prognosis in such patients, functional class is a more important factor. Conclusion Patients with valvular heart disease should have the severity of their valvular disease and functional class determined by a cardiologist before urgent or elective surgical operations or pregnancy. The cardiologist can then determine if the patients can undergo the operation with an acceptable risk. If the valvular lesions are far advanced, first cardiac and later the non-cardiac surgery should be done. References 1. Vesay LG. Lessons learned from the resurgence of rheumatic fever in the United States. Rheumatic Fever. Washington, DC. Armed Forces Institute of Pathology 1999; 69-78. 2. Connoly HM, Oh JK, Orszulak TA. Aortic valve replacement for aortic stenosis with severe LV dysfunction. Circulation 1997; 95: 2395-2400. 3. Bonow RO, Corabello B, deleon AC, Jr. ACC-AHA guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998; 32: 1486-588. 4. Roguin A, Reinkerich D, Milo S. Long-term follow-up of patients with severe rheumatic tricuspid stenosis. Am Heart J 1998; 136: 103-108. 5. Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in mitral regurgitation. J Am Coll Cardiol 1999; 33: 538-45. 6. Crawford MH, DiMarco JP. Cardiology. Mitral valve disease. Mitral stenosis. Harcourt Health Sciences, 2001: 6.4.1. 7. Wisenbaugh T, Span JF, Carabells BA. Differences in myocardial performance and load between patients with similar amount of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1998; 3: 916-23. 8. Rehm SJ. Outpatient intravenous antibiotic therapy for endocarditis. Infect Dis Clin N Am 1998; 12: 879-901. 9. Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic heart disease. Am J Cardiol 1996; 77: 96-8. 10. Eagle KA, Brundage BH, Chaitman BR. Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. Circulation 1996; 93: 1278-1317.

11. Fuster V, Wayne R, O Rourke RA. The Heart. Perioperative evaluation of patients with known cardiovascular disease who undergo non-cardiac surgery. McGraw-Hill, 2001; 2137-2138. 12. Crawford MH, DiMarco JP. Cardiology. Aortic valve disease. Harcourt Health Sciences, 2001; 6.9.1. 13. Cunningham, F, Paul C, Norman F, et al. Williams Obstetrics. Cardiovascular Disease in Pregnancy. Prentice Hall International Inc. 1997; 1079-1087.